Danimer Scientific, Inc.
DNMR · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,175,187 | $2,620,464 | $4,366,672 | $4,167,511 |
| - Cash | $22,187 | $40,254 | $57,341 | $59,170 |
| + Debt | $413,037 | $419,070 | $410,240 | $408,068 |
| Enterprise Value | $2,566,037 | $2,999,280 | $4,719,571 | $4,516,409 |
| Revenue | $8,630 | $7,628 | $10,224 | $10,945 |
| % Growth | 13.1% | -25.4% | -6.6% | – |
| Gross Profit | -$7,315 | -$6,903 | -$8,695 | -$8,592 |
| % Margin | -84.8% | -90.5% | -85% | -78.5% |
| EBITDA | -$18,821 | -$6,149 | -$10,991 | -$23,460 |
| % Margin | -218.1% | -80.6% | -107.5% | -214.3% |
| Net Income | -$21,839 | -$22,661 | -$27,263 | -$39,434 |
| % Margin | -253.1% | -297.1% | -266.7% | -360.3% |
| EPS Diluted | -7.2 | -0.19 | -0.26 | -0.39 |
| % Growth | -3,689.5% | 26.9% | 33.3% | – |
| Operating Cash Flow | -$14,499 | -$18,970 | -$12,991 | $17,363 |
| Capital Expenditures | -$3,716 | -$1,800 | -$1,970 | -$1,963 |
| Free Cash Flow | -$18,215 | -$20,770 | -$14,961 | $15,400 |